Coverage
12 companies
- Lead links
- 2
- Instruments
- Equity / unspecified
- Sourced relationships
- 12
- Distinct source URLs
- 23
- Crawl status
- Official page mapped
Sourced investor record
Cambridge Innovation Capital
Cambridge ecosystem portfolio source
Portfolio links122 lead relationships
- Indexing state
- Evidence-qualified
- Latest dated link
- 2026-01-01
- Earliest dated link
- 2016-12-15
- Snapshot
- 2026-08-25
Official source
Portfolio located
Open official portfolio ↗Evidence ledger
12 retained relationships
A link records a disclosed or retained research relationship; it does not imply a current holding. Every row exposes the source layer, observation date, match method and publication state. Exact dated matches link onward to the funding record.
Observed roles
Evidence threshold
This page meets the retained indexing threshold through an official portfolio URL, three or more linked companies or two distinct relationship-source URLs.
12 relationships shown
| Company | Role | Round | Date | Named sources | Match / state |
|---|---|---|---|---|---|
| Nuclera | participant | Series C | 2026-01-01 | Nuclera ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Pragmatic Semiconductor | participant | Series D | 2023-12-01 | Pragmaticsemi ↗ · Wsgr ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| CMR Surgical | participant | Series D (2021) + follow-on round (2023, stage/series label unclear), Series F | 2025-04-02 | Sifted ↗ · Fiercebiotech ↗ · Cambridgenetwork ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Seldon | participant | Series B | 2023-03-16 | TechCrunch ↗ · PR Newswire ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Storm Therapeutics | lead | Series B | 2022-12-01 | Stormtherapeutics ↗ · Cancerresearchhorizons ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| PetMedix | participant | Series B | 2021-09-01 | UKTN ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Origami Energy | participant | Series C | 2021-06-03 | UKTN ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Congenica | participant | Series B | 2019-04-01 | Congenica ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Cytora | participant | Series A, Series B | 2019-04-16 | Cytora ↗ · TechCrunch ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Bicycle Therapeutics | participant | Series B | 2017-06-01 | Svhealthinvestors ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Microbiotica | lead; participant | Seed, Series B | 2022-03-07 | Microbiotica ↗ · Business Wire ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Riverlane | participant | Not stated | 2026-08-25 | Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Recent linked companies
12 of 12 observed companies
The most recently dated retained relationships are shown first; the complete sourced set remains in the ledger above.
NucleraOpen company recordPragmatic SemiconductorOpen company recordCMR SurgicalOpen company recordSeldonOpen company recordStorm TherapeuticsOpen company recordPetMedixOpen company recordOrigami EnergyOpen company recordCongenicaOpen company recordCytoraOpen company recordBicycle TherapeuticsOpen company recordMicrobioticaOpen company recordRiverlaneOpen company record